Patent · US Active

Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders

US9833450B2 · kind B2 · utility

9Cited by

17References

20Claims

0Family size

Assignees

Lixte Biotechnology, Inc. · US
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

John S. Kovach · Rochester, US
Salvatore Lecca · Paris, FR
Manuel Mameli · Paris, FR

Key dates

Filing date	Feb 19, 2016
Grant date	Dec 5, 2017
Priority date	—
Expiry date	Feb 19, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D493/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating a depressive or stress disorder in a subject afflicted therewith comprising administering to the subject an effective amount of a compound having the structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.